Bone biopsy results and serum bone turnover parameters in uremic children

H Ziólkowska1, M Pańiczyk-Tomaszewska, A Debiński

  • 1Department of Paediatrics and Nephrology, Warsaw University Medical School, Poland.

Insights

This study found that biochemical markers have limited use in diagnosing different types of renal osteodystrophy in children with end-stage renal failure. Bone biopsy remains crucial for accurate diagnosis of these bone diseases.

Area of Science:

  • Pediatric Nephrology
  • Bone Metabolism
  • Renal Osteodystrophy

Background:

  • Renal osteodystrophy (ROD) is a common complication in children with end-stage renal failure.
  • Accurate diagnosis of ROD types is essential for appropriate management.
  • Current diagnostic methods may have limitations.

Purpose of the Study:

  • To determine the prevalence of different renal osteodystrophy types in children on hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD).
  • To evaluate the utility of biochemical parameters in diagnosing ROD.
  • To correlate biochemical markers with bone histology.

Main Methods:

  • Bone biopsy and serum measurements of parathormone (iPTH), alkaline phosphatase (AP), osteocalcin (OC), procollagen 1C, calcium, and phosphorus.
  • Analysis of data from 51 children with end-stage renal failure.
  • Comparison of ROD types between HD and CAPD groups.

Main Results:

  • Prevalence of ROD types: adynamic bone disease (ABD) in 27%, normal bone (NB) in 37%, osteomalacia (OM) in 2%, mixed lesion (Mix) in 10%, and hyperparathyroidism (HP) in 24%.
  • No significant difference in ROD type prevalence between CAPD and HD.
  • Significant differences in iPTH, OC, and AP levels were observed between HP, NB, and ABD groups.
  • ABD was more common with PTH < 50 pg/ml; HP was more common with iPTH > 200 pg/ml.
  • High correlation found between bone formation rate (BFR) and iPTH, OC, and AP levels.

Conclusions:

  • Biochemical markers of bone turnover have limited value in differentiating renal osteodystrophy types.
  • Bone biopsy remains a valuable tool for diagnosing ROD in pediatric patients.
  • Further research may be needed to identify more reliable biochemical markers.
Abstract

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.